Mark D Griffiths Selected Research

Immunoglobulin D (IgD)

3/2021	Depression and anxiety symptoms associated with internet gaming disorder before and during the COVID-19 pandemic: A longitudinal study.
12/2020	Depression, anxiety, and stress mediate the associations between internet gaming disorder, insomnia, and quality of life during the COVID-19 outbreak.
11/2020	Internet gaming as a coping method among schizophrenic patients facing psychological distress.
1/2020	Parent-adolescent attachment and peer attachment associated with Internet Gaming Disorder: A longitudinal study of first-year undergraduate students.
1/2019	Psychosocial factors mediating the relationship between childhood emotional trauma and internet gaming disorder: a pilot study.
1/2018	Neurobiological Correlates in Internet Gaming Disorder: A Systematic Literature Review.
1/2018	Conceptual Issues Concerning Internet Addiction and Internet Gaming Disorder: Further Critique on Ryding and Kaye (2017).
11/2017	Measurement Invariance of the Internet Gaming Disorder Scale-Short-Form (IGDS9-SF) between the United States of America, India and the United Kingdom.
6/2017	Chaos and confusion in DSM-5 diagnosis of Internet Gaming Disorder: Issues, concerns, and recommendations for clarity in the field.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark D Griffiths Research Topics

Disease

13	COVID-19 11/2022 - 10/2020
5	Gambling (Pathological Gambling) 06/2022 - 09/2015
4	Substance-Related Disorders (Drug Abuse) 04/2022 - 06/2018
2	Infections 01/2021 - 10/2020
2	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2020 - 01/2020
2	Mental Disorders (Mental Disorder) 01/2020 - 01/2018
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 11/2017 - 06/2013
1	Specific Phobia 01/2022
1	Overweight 12/2021
1	Breast Neoplasms (Breast Cancer) 12/2021
1	Human Influenza (Influenza) 10/2021
1	Feeding and Eating Disorders (Eating Disorder) 06/2021
1	Bulimia (Binge Eating) 06/2021
1	Schizophrenia (Dementia Praecox) 11/2020
1	Atrophy 01/2020
1	Heart Failure 01/2020
1	Alcoholism (Alcohol Abuse) 01/2019
1	Warts (Wart) 01/2019
1	Wounds and Injuries (Trauma) 01/2019
1	Death (Near-Death Experience) 01/2018
1	Confusion (Bewilderment) 06/2017
1	Fibromyalgia (Fibrositis) 02/2017
1	Compulsive Sexual Behavior Disorder 06/2016
1	Psychotic Disorders (Schizoaffective Disorder) 02/2014

Drug/Important Bio-Agent (IBA)

9	Immunoglobulin D (IgD)IBA 03/2021 - 06/2017
4	COVID-19 VaccinesIBA 11/2022 - 10/2021
3	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2022 - 01/2020
3	VaccinesIBA 11/2021 - 01/2021
3	Indicators and Reagents (Reagents)IBA 01/2019 - 09/2015
2	SuspensionsIBA 02/2021 - 10/2020
2	Pharmaceutical PreparationsIBA 01/2019 - 06/2018
2	Biological ProductsIBA 01/2018 - 12/2017
1	Influenza Vaccines (Influenza Vaccine)FDA Link 11/2022
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 04/2022
1	Illicit Drugs (Recreational Drugs)IBA 01/2022
1	SolutionsIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	BESIBA 06/2021
1	Prostaglandins AIBA 06/2020
1	Estrogens (Estrogen)FDA Link 01/2020
1	Adenosine Monophosphate (AMP)IBA 01/2019
1	Nicotine FDA Link 06/2018

Therapy/Procedure

4	Behavior Control 12/2021 - 06/2021
4	Meditation 01/2018 - 06/2013
2	Therapeutics 06/2022 - 02/2014
1	Self Medication 11/2020